Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulators | Patent Publication Number 20210017168
US 20210017168 A1Patent NumberUS 11618750 B2
Application Number16899823
Filled DateJun 12, 2020
Priority DateJun 14, 2019
Publication DateJan 21, 2021
Original AssigneeJohnson & Johnson
Current AssigneeJanssen Pharmaceuticals Johnson & Johnson
Inventor/ApplicantsMichael A. LETAVIC
Andrew Samant
Akinola SOYODE-JOHNSON
Christa Chrovian
Christine GELIN
Brice STENNE
Michael A. Letavic
Curt DVORAK
Christa CHROVIAN
Brice Stenne
Curt Dvorak
Afton Hiscox
Afton HISCOX
Andrew SAMANT
Akinola Soyode-Johnson
Christine Gelin
Andrew Samant
Akinola SOYODE-JOHNSON
Christa Chrovian
Christine GELIN
Brice STENNE
Michael A. Letavic
Curt DVORAK
Christa CHROVIAN
Brice Stenne
Curt Dvorak
Afton Hiscox
Afton HISCOX
Andrew SAMANT
Akinola Soyode-Johnson
Christine Gelin
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.